Our RESETTM clinical trials with CABA-201 (investigational CD19-CAR T cell therapy) in lupus, myositis, systemic sclerosis, myasthenia gravis, and pemphigus vulgaris are now recruiting.
Posters & Publications
Learn more about our scientific research through posters at leading conferences and publications in peer-reviewed journals.
Examine Our Findings